Login Register Cart 0
Generic placeholder image

Current Bioactive Compounds

Editor-in-Chief

ISSN (Print): 1573-4072
ISSN (Online): 1875-6646

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Research Article

Design, Synthesis and Biological Evaluation of 2-Aminobenzimidazole Derivatives as DPP4 Inhibitors

Author(s): Sreeja Sunil*, Arul G.D.A. Smith and Mathan S.

Volume 16, Issue 5, 2020

Page: [696 - 702] Pages: 7

DOI: 10.2174/1573407215666190318121902

Price: $65

Abstract

Background: The objective of the research was to examine the DPPIV inhibitor activity of synthetic derivatives of 2-aminobenzimidazole derivatives by the in-vivo method.

Methods: Molecular docking was performed using homology model of receptors to identify the binding sites for the inhibitory activity of diabetes by means of- CDocker energy using the Discovery Studio (DS) 4.5 Novel 2-amino benzimidazole derivatives were synthesized from orthophenylene diamine with cyanogens bromide. The synthesized compounds were identified by IR,1HNMR,13CNMR, and MASS spectroscopic techniques. The products were analyzed for their DPPIV inhibitory effects on Wistar Albino rat.

Results: The results revealed that benzimidazole with para-aminobenzoic acid possesses best DPPIV inhibitor activity. 2- amino benzimidazole incorporated with aromatic compounds were synthesized and assessed for their DPP-IV inhibitor activity.

Conclusion: 2- amino benzimidazole with para-aminobenzoic acid can be used as a lead compound for the development of a new class of DPP-IV inhibitor.

Keywords: 2-amino benzimidazole, docking, DPPIV inhibitor, sitagliptin, antihypertensive, spectroscopy.

Graphical Abstract

[1]
Laurentina, M.; Delmia, D.; Roy, G.M.; Muhammed, K. Prevalence of kidney dysfunction in diabetes mellitus and associated risk factor among productive age Indonesian. J. Diabetes Metab. Disord., 2017, 16, 46.
[2]
Jane, L; Chiang, M; Sue, K. Type1Diabetes through the lifespan: A position statement of American Diabetes Association. American Diabetes Association., 2014, 37, 2034-2054.
[3]
Mohammed; Asif. The prevention and control the type 2 diabetes by changing lifestyle and dietary pattern. J. Educ. Health Promot., 2014, 1, 1-3.
[4]
Senten, K. Synthesis and SAR of potent and selective dipeptide derived inhibitors of DPP4. J. Med. Chem., 2003, 46, 5005-5014.
[http://dx.doi.org/10.1021/jm0308803] [PMID: 14584950]
[5]
Shivani, S. Priyashree; Yamini, B. Active phytochemicals of Pueraria tuberose for DPPIV -Inhibition; in silico and experimental approach. J. Diabetes Metab. Disord., 2017, 16, 46.
[http://dx.doi.org/10.1186/s40200-017-0328-0] [PMID: 29201861]
[6]
Alam, F.; De, y B.K; Chakraborty, A. Synthesis characterization and pharmacological screening of some benzimidazole derivatives. Int. J. Pharm., 2014, 5, 325-331.
[7]
Hosseinzadiha, N.; Seraj, S.; Bakhshi-Dezffoli, M.E. Hasan,i M. Synthesis and antidiabetic evaluation of benzenesulfonamide derivatives. Iran. J. Pharm. Res., 2013, 12, 325-330.
[8]
Islam, I.; Skibo, E.B.; Dorr, R.T.; Alberts, D.S. Structure-activity studies of antitumor agents based on pyrrolo[1,2-a]benzimidazoles: new reductive alkylating DNA cleaving agents. J. Med. Chem., 1991, 34(10), 2954-2961.
[http://dx.doi.org/10.1021/jm00114a003] [PMID: 1920349]
[9]
Taha, M.; Ismail, N.H.; Jamil, W.; Rashwan, H.; Kashif, S.M.; Sain, A.A.; Adenan, M.I.; Anouar, H.; Ali, M.; Rahim, F.; Khan, K.M. Synthesis of novel derivatives of 4-methylbenzimidazole and evaluation of their biological activities. Eur. J. Med. Chem., 2014, 84, 731-738.
[http://dx.doi.org/10.1016/j.ejmech.2014.07.078] [PMID: 25069019]
[10]
Accelrys Software Inc. Discovery Studio Modelling Environment, Releasee 3.5;
[11]
Vinodkumar, R.; Vaidya, S.D.; Siva Kumar, B.V.; Bhise, U.N.; Bhirud, S.B.; Mashelkar, U.C. Synthesis, anti-bacterial, anti-asthmatic and anti-diabetic activities of novel N-substituted-2-(4-phenylethynyl-phenyl)-1H-benzimidazoles and N-substituted 2[4-(4,4-dimethyl-thiochroman-6-yl-ethynyl)-phenyl)-1H-benzimidazoles. Eur. J. Med. Chem., 2008, 43(5), 986-995.
[http://dx.doi.org/10.1016/j.ejmech.2007.06.013] [PMID: 17825955]
[12]
Yang, S.Y. Pharmacophore modeling and applications in drug discovery: challenges and recent advances. Drug Discov. Today, 2010, 15(11-12), 444-450.
[http://dx.doi.org/10.1016/j.drudis.2010.03.013] [PMID: 20362693]
[13]
Kitchen, D.B.; Decornez, H.; Furr, J.R.; Bajorath, J. Docking and scoring in virtual screening for drug discovery: methods and applications. Nat. Rev. Drug Discov., 2004, 3(11), 935-949.
[http://dx.doi.org/10.1038/nrd1549] [PMID: 15520816]
[14]
Loganathan, C.; Sakkiah, S.; Lee, K.W.; Kabilan, S.; Meganathan, C. Pharmacophore design, virtual screening, molecular docking and optimization approaches to discover potent thrombin inhibitors. Comb. Chem. High Throughput Screen., 2013, 16(9), 702-720.
[http://dx.doi.org/10.2174/13862073113169990007] [PMID: 23713461]
[15]
Rudnitskaya, A.; Török, B.; Török, M. Molecular docking of enzyme inhibitors: A computational tool for structure-based drug design. Biochem. Mol. Biol. Educ., 2010, 38(4), 261-265.
[http://dx.doi.org/10.1002/bmb.20392] [PMID: 21567838]
[16]
Brooks, B.R.; Bruccoleri, R.E.; Olafson, B.D.; States, D.J.; Swaminathan, S.; Karplus, M. CHARMM: a program for macromolecular energy minimisation and dynamic calculations. J. Comput. Chem., 1983, 4, 187-217.
[http://dx.doi.org/10.1002/jcc.540040211]
[17]
Noolvi, M.; Agrawal, S.; Patel, H.; Badiger, A.; Gaba, M.; Zambra, A. Synthesis antimicrobial activity of novel azetidine-2-one derivatives of 1H-benzimidazole. Arab. J. Chem., 2014, 7, 219-226.
[http://dx.doi.org/10.1016/j.arabjc.2011.02.011]
[18]
Adnan, S.; Hassan, K.; Thamer, H. Synthesis and identification some of heterocyclic compounds from 2-Aminobenzimidazole. Iraqui. National. J. Chem., 2014, 53, 66-75.
[19]
Noufal, Z.M.; Fahmy, H.M.; Mohammed, H.S. Synthesis antimicrobial and molluscicidal activities of new benzimidazole derivatives. Arch. Pharm. (Weinheim), 2001, 25, 28-38.
[20]
Mobinikhaledi, A.; Asghari, B.; Jabbarpour, M. Design and synthesis of new benzimidazole and pyrimidine derivatives as α- glucosidase inhibitor. Iran. J. Pharm. Res., 2015, 14(3), 723-731.
[PMID: 26330860]
[21]
Yousuf Ali, M.D. Pau.l S; Tanvir, E.M; Hossein, S. Antihyperglycemic, antidiabetic, and antioxidant effects of Garcinia pedunculata in rats. Evid. Based Complement. Alternat. Med., 2017, 2017, 60.
[22]
lla, D.A; Gomtzer, E; Wendelin, W. Synthesis and structural elucidation of pyrimido-[1,2-a] benzimidazole and fused derivatives of dehydropyrimido [1,2-a] benzimidazoles. J. Heterocycl. Chem., 1996, 33, 373.
[http://dx.doi.org/10.1002/jhet.5570330228]
[23]
Kagal, U.A.; Angadi, N.B.; Matule, S.M. Effect of dipeptidyl peptidase 4 inhibitors on acute and subacute models of inflammation in male Wistar rats: An experimental study. Int. J. Appl. Basic Med. Res., 2017, 7(1), 26-31.
[http://dx.doi.org/10.4103/2229-516X.198516] [PMID: 28251104]

Rights & Permissions Print Cite
Article Metrics
9
© 2024 Bentham Science Publishers | Privacy Policy